Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 2, 2009, Pages 290-295

  Zuo, Dai Ying ^a   Cao, Yue ^b   Zhang, Lan ^a   Wang, Hai Feng ^a   Wu, Ying Liang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Liaoning Institute for Drug Control   (China)

Author keywords

c Fos protein; Clozapine; MK 801; Schizophrenia

Indexed keywords

CLOZAPINE; DIZOCILPINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CINGULATE GYRUS; COMPARATIVE STUDY; CONTROLLED STUDY; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; CLOZAPINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GENES, FOS; IMMUNOHISTOCHEMISTRY; MALE; MICE; PROTO-ONCOGENE PROTEINS C-FOS; SCHIZOPHRENIA;

EID: 60049097211     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.12.002     Document Type: Article

References (44)

1. Arvanov V.L., and Wang R.Y. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-d-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharmacol Exp Ther 289 (1999) 1000-1006
2. Ashby Jr. C.R., and Wang R.Y. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24 (1996) 349-394
3. Becker A., Peters B., Schroeder H., Mann T., Huether G., and Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 687-700
4. Brosnan-Watters G., Wozniak D.F., Nardi A., and Olney J.W. Parallel recovery of MK-801-induced spatial learning impairment and neuronal injury in male mice. Pharmacol Biochem Behav 62 (1999) 111-122
5. G-nitro-l-arginine methyl ester on phencyclidine-induced effects in rats. Eur J Pharmacol 409 (2000) 57-65
6. Carlsson A. Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 10 Suppl 3 (1995) 21-28
7. Duncan G.E., Moy S.S., Knapp D.J., Mueller R.A., and Breese G.R. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787 (1998) 181-190
8. Duncan G.E., Sheitman B.B., and Lieberman J.A. An integrated view of pathophysiological models of schizophrenia. Brain Res. Brain Res Rev 29 (1999) 250-264
9. Farber N.B., Foster J., Duhan N.L., and Olney J.W. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr Res 21 (1996) 33-37
10. Farber N.B., Kim S.H., Dikranian K., Jiang X.P., and Heinkel C. Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry 7 (2002) 32-43
11. Filipkowski R.K., Rydz M., Berdel B., Morys J., and Kaczmarek L. Tactile experience induces c-fos expression in rat barrel cortex. Learn Mem 7 2 (2000) 116-122
12. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (1997), Academic Press, San Deigo
13. Fujimura M., Hashimoto K., and Yamagami K. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine. Eur J Pharmacol 398 (2000) 1-10
14. Gao X.M., Hashimoto T., and Tamminga C.A. Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29 (1998) 14-28
15. Graybiel A.M., Moratalla R., and Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci U S A 87 (1990) 6912-6916
16. Herrera D.G., and Robertson H.A. Activation of c-fos in the brain. Prog Neurobiol 50 (1996) 83-107
17. Hughes P., Dragunow M., Beilharz E., Lawlor P., and Gluckman P. MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones. NeuroReport 4 (1993) 183-186
18. Hughes P., and Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 7 (1995) 133-178
19. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
20. Koek W., Woods J.H., and Winger G.D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245 (1988) 969-974
21. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
22. Li Q., Clark S., Lewis D.V., and Wilson W.A. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 22 (2002) 3070-3080
23. Lidow M.S., Williams G.V., and Goldman-Rakic P.S. The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol Sci 19 (1998) 136-140
24. Moghaddam B., and Jackson M.E. Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003 (2003) 131-137
25. Nakao S., Miyamoto E., Masuzawa M., Kambara T., and Shingu K. Ketamine-induced c-Fos expression in the mouse posterior cingulated and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res 926 (2002) 191-196
26. Ninan I., and Kulkarni S.K. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. Indian J Physiol Pharmacol 42 (1998) 375-382
27. Nishizawa N., Nakao S., Nagata A., Hirose T., Masuzawa M., and Shingu K. The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices. Brain Res 57 (2000) 188-192
28. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995) 998-1007
29. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
30. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., and Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science 254 (1991) 1515-1518
31. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33 (1999) 523-533
32. Rajdev S., Fix A.S., and Sharp F.R. Acute phencyclidine neurotoxicity in rat forebrain: induction of haem oxygenase-1 and attenuation by the antioxidant dimethylthiourea. Eur J Neurosci 10 (1998) 3840-3852
33. Sayed M.A.N., Noda Y., Mahmoud Hamdy M., Mamiya T., Nagai T., Furukawa H., et al. Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain. Behav Brain Res 124 (2001) 71-76
34. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
35. Sgambato V., Abo V., Rogard M., Besson M.J., and Deniau J.M. Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81 (1997) 93-112
36. Sharma T., and Mockler D. The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18 2 Suppl 1 (1998) 12S-19S
37. Sharp F.R., Butman M., Wang S., Koistinaho J., Graham S.H., Sagar S.M., et al. Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J Neurosci Res 33 (1992) 605-616
38. Silbersweig D., and Stern E. Functional neuroimaging of hallucinations in schizophrenia: toward an integration of bottom-up and top-down approaches. Mol Psychiatry 1 (1996) 367-375
39. Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav Brain Res 74 (1996) 45-55
40. Sugita S., Namima M., Nabeshima T., Okamoto K., Furukawa H., and Watanabe Y. Phencyclidine-induced expression of c-Fos-like immunoreactivity in mouse brain regions. Neurochem Int 28 (1996) 545-550
41. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42 (2002) 165-179
42. Umino A., Nishikawa T., and Takahashi K. Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem Int 26 (1995) 85-90
43. Zuo D.Y., Zhang Y.H., Cao Y., Wu C.F., Tanaka M., and Wu Y.L. Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior. Life Sci 78 (2006) 2172-2178
44. Zuo D.Y., Wu Y.L., Yao W.X., Cao Y., Wu C.F., and Tanaka M. Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacol Biochem Behav 86 (2007) 1-7